Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide

[1]  L. Xue,et al.  Intensive cholesterol-lowering therapy improves large artery elasticity in acute myocardial infarction patients , 2009, Heart and Vessels.

[2]  A. Kırış,et al.  Low total antioxidative capacity levels are associated with augmentation index but not pulse-wave velocity , 2009, Heart and Vessels.

[3]  C. Giannarelli,et al.  Atorvastatin Prevents Endothelial Dysfunction in Mesenteric Arteries From Spontaneously Hypertensive Rats: Role of Cyclooxygenase 2–Derived Contracting Prostanoids , 2009, Hypertension.

[4]  K. Carvajal,et al.  Castration modifies aortic vasoreactivity and serum fatty acids in a sucrose-fed rat model of metabolic syndrome , 2009, Heart and Vessels.

[5]  J. Mitchell,et al.  Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium , 2008, Experimental physiology.

[6]  J. Robinson,et al.  A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2 , 2008, Climacteric : the journal of the International Menopause Society.

[7]  I. Kosmidou,et al.  Statin Treatment and 3′ Polyadenylation of eNOS mRNA , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Hong Yang,et al.  Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues. , 2007, The Biochemical journal.

[9]  M. Geraci,et al.  Genetic and Epigenetic Regulation of the Human Prostacyclin Synthase Promoter in Lung Cancer Cell Lines , 2007, Molecular Cancer Research.

[10]  Akitoshi Yoshida,et al.  Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways. , 2007, Investigative ophthalmology & visual science.

[11]  D. Garvey,et al.  Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. , 2007, Current topics in medicinal chemistry.

[12]  Yang Zeng,et al.  Differentiation of human umbilical cord blood stem cells into hepatocytes in vivo and in vitro. , 2006, World journal of gastroenterology.

[13]  F. Cipollone,et al.  Cyclooxygenase-2 inhibition: Vascular inflammation and cardiovascular risk , 2006, Current atherosclerosis reports.

[14]  V. Moreno,et al.  Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy , 2005, Oncogene.

[15]  Y. Ikeda,et al.  Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene. , 2005, Metabolism: clinical and experimental.

[16]  H. Kasanuki,et al.  Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia , 2005, Heart and Vessels.

[17]  S. Heinemann,et al.  The influence of statins on the free intracellular calcium concentration in human umbilical vein endothelial cells , 2004, BMC cardiovascular disorders.

[18]  P. Marsden,et al.  Endothelial Nitric Oxide Synthase: A New Paradigm for Gene Regulation in the Injured Blood Vessel , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[19]  H. Nisell,et al.  The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[20]  N J Wald,et al.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[21]  B. Suwelack,et al.  Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  J. Liao,et al.  Endothelium-Dependent Effects of Statins , 2003 .

[23]  L. Levine.  Statins stimulate arachidonic acid release and prostaglandin I2 production in rat liver cells , 2003, Lipids in Health and Disease.

[24]  A. Zeiher,et al.  Double-Edged Role of Statins in Angiogenesis Signaling , 2002, Circulation research.

[25]  C. Heeschen,et al.  Statins Have Biphasic Effects on Angiogenesis , 2002, Circulation.

[26]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[27]  H. Arnesen,et al.  Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. , 2001, Atherosclerosis.

[28]  S. Heidenreich,et al.  Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation. , 2001, Kidney international.

[29]  M. Herrera,et al.  Effect of simvastatin on vascular smooth muscle responsiveness: involvement of Ca(2+) homeostasis. , 2001, European journal of pharmacology.

[30]  M. A. Iñiguez,et al.  Human Vascular Smooth Muscle Cells but Not Endothelial Cells Express Prostaglandin E Synthase , 2000, Circulation research.

[31]  A. Corsini.  Fluvastatin: effects beyond cholesterol lowering. , 2000, Journal of cardiovascular pharmacology and therapeutics.

[32]  A. Corsini.  Fluvastatin: effects beyond cholesterol lowering. , 2000, Journal of cardiovascular pharmacology and therapeutics.

[33]  A. Mueck,et al.  Fluvastatin increases prostacyclin and decreases endothelin production by human umbilical vein endothelial cells. , 2000, International journal of clinical pharmacology and therapeutics.

[34]  J. Farmer.  Pleiotropic effects of statins , 2000, Current atherosclerosis reports.

[35]  F. Bernini,et al.  Pleiotropic effects of statins in atherosclerosis and diabetes. , 2000, Diabetes care.

[36]  T. Strandberg,et al.  Associations between change in C-reactive protein and serum lipids during statin treatment , 2000, Annals of medicine.

[37]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[38]  C. Packard,et al.  Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. , 1997, The Journal of clinical endocrinology and metabolism.

[39]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[40]  松尾 高.  Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia , 2008 .

[41]  K. Kublickiene,et al.  Implications for Endothelium-Derived Hyperpolarizing Factor (EDHF) in Womens Cardiovascular Health , 2005 .

[42]  W. Palinski,et al.  New evidence for beneficial effects of statins unrelated to lipid lowering. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[43]  Wulf Palinsk.  New Evidence for Beneficial Effects of Statins Unrelated to Lipid Lowering , 2001 .

[44]  R. Caldwell,et al.  Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. , 1999, Journal of the American College of Cardiology.